“…Taken together, these data suggest that somatic MED12 mutations may play a functional role in smooth muscle tumors. In accord with this notion, analysis of major cancer types including other types of sarcoma, as well as colon, breast, and lung carcinomas and gastrointestinal stromal tumor showed MED12 mutations exclusively in leiomyomas of the uterus (Je et al, 2012) (Bertsch et al, 2014) in smooth muscle tumors has been observed and general functional data regarding MED12 indicate a major role during developmental processes (Gillmor et al 2014;Wu et al, 2014) and in the modulation of sonic hedgehog (Zhou et al, 2006), TGFß signaling (Huang et al, 2012), and Wntsignaling Rocha et al, 2010); the latter being in line with the detection of MED12 mutations in colorectal cancer (Je et al, 2012;Forbes et al, 2014).…”